Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by PressReach

< Previous 1 2 3 4 5 6 7 8 9
...
37 38 Next >
Alzamend Neuro Partners with Massachusetts General Hospital for a Phase II Clinical Trial of AL001, a Next‑Generation Lithium Therapeutic Drug Candidate, involving Patients with Post-Traumatic Stress Disorder
Via PressReach
Exposures Product Safety
Tickers ALZN
Surf Air Mobility Reports Second Quarter Financial Results, Exceeding Expectations
Via PressReach
Tickers SRFM
E3 Lithium to Receive $5 Million From the Government of Alberta for its Fully Integrated Demonstration Facility
Via PressReach
Topics Economy Electric Vehicles Emissions
Exposures Economy Electric Vehicles
Tickers EEMMF TSX-V:ETL
Generation Uranium Initiates Permitting Process on Its Flagship Yath Uranium Project in Nunavut, Canada
Via PressReach
Tickers GENRF TSX-V:GEN
Bitbuy APAC is Now Live in Australia
Via PressReach
Tickers ASX:KGN TSX:WNDR WONDF
Generation Uranium Announces DTC Eligibility
Via PressReach
Tickers GENRF TSX-V:GEN
Knightscope Reseller Issues 23-Device Purchase Order in Healthcare
Via PressReach
Topics Artificial Intelligence
Exposures Artificial Intelligence
Tickers KSCP
Surf Air Mobility Announces Plan to Form New Venture, Surf Air Technologies LLC, and Enters Agreement with Palantir Technologies Inc. to Power Operating System for the Advanced Air Mobility Industry
Via PressReach
Topics Artificial Intelligence
Exposures Artificial Intelligence
Tickers PLTR SRFM
West Red Lake Gold Intersects 107.61 g/t Au over 2.5m at Austin and 106.99 g/t Au over 2.35m at McVeigh – Madsen Mine
Via PressReach
Tickers WRLGF
University Expands Emergency Communication Conversion with Knightscope (NASDAQ:KSCP)
Via PressReach
Topics Artificial Intelligence
Exposures Artificial Intelligence
Tickers KSCP
New Study Reveals How Classical Music Could Revolutionize Depression Care
Via PressReach
Exposures Product Safety
Tickers ALZN AXSM BIIB NBIX
Alzamend Neuro Partners with Massachusetts General Hospital for Phase II Trial of Next-Generation Treatment for Major Depressive Disorder
Via PressReach
Exposures Product Safety
Tickers ALZN
Alzamend Neuro Partners with Massachusetts General Hospital for a Phase II Clinical Trial of AL001, a Next‑Generation Lithium Therapeutic Drug Candidate, involving Patients with Major Depressive Disorder
Via PressReach
Exposures Product Safety
Tickers ALZN
Surf Air Mobility Announces Closing of $35.2 Million Mandatory Convertible Security with GEM Global Yield LLC
Via PressReach
Tickers SRFM
Two New Sales for Knightscope’s Emergency Communications
Via PressReach
Topics Artificial Intelligence
Exposures Artificial Intelligence
Tickers KSCP
E3 Lithium Plans to Construct a Fully Integrated Lithium Demonstration Facility
Via PressReach
Topics Economy Supply Chain
Exposures Supply Chain
Tickers EEMMF TSX-V:ETL
Anthony Milewski Unveils Monthly Newsletter for Mastering Market Speculation
Via PressReach
Huntington Park Police Renews Knightscope Partnership for Sixth Year as Crime Rates Drop
Via PressReach
Topics Artificial Intelligence
Exposures Artificial Intelligence
Tickers KSCP
Surf Air Mobility to Provide Second Quarter 2024 Financial Results on August 14, 2024
Via PressReach
Tickers SRFM
Revolutionary Magnetic Therapy Could Speed Up Bipolar Treatment
Via PressReach
Exposures Product Safety
Tickers ABBV ALZN ITCI TEVA
Alzamend Neuro Partners with Massachusetts General Hospital for Phase II Trial of AL001, a Next-Generation Lithium Therapeutic Drug Candidate, involving Patients with Bipolar Disorder and Alzheimer’s Disease
Via PressReach
Exposures Product Safety
Tickers ALZN
Alzamend Neuro Partners with Massachusetts General Hospital for a Phase II Clinical Trial of AL001, a Next-Generation Lithium Therapeutic Drug Candidate, involving Patients with Bipolar Disorder
Via PressReach
Exposures Product Safety
Tickers ALZN
Alzamend Neuro Partners with Massachusetts General Hospital for a Phase II Clinical Trial of AL001, a Next-Generation Lithium Therapeutic Drug Candidate, involving Patients with Alzheimer’s Disease
Via PressReach
Tickers ALZN
The Future of AI Robotics: Generative AI and RaaS Poised for Rapid Growth
Via PressReach
Topics Artificial Intelligence
Exposures Artificial Intelligence
Tickers C KSCP NVDA SERV
Huntington Park Police Renews Knightscope Contract for 6th Year
Via PressReach
Topics Artificial Intelligence
Exposures Artificial Intelligence
Tickers KSCP
Xcyte Digital Corp. Announces Advanced AI-Powered Captioning and Translation Features
Via PressReach
Topics Artificial Intelligence
Exposures Artificial Intelligence
Tickers AMZN TSX-V:XCYT
Abaxx and MineHub Forge Strategic Partnership to Revolutionize Commodities Markets
Via PressReach
Topics Climate Change Economy
Exposures Climate Supply Chain
Tickers TSX-V:MHUB
School and Transit Clients Expand Knightscope Contracts
Via PressReach
Topics Artificial Intelligence
Exposures Artificial Intelligence
Tickers KSCP
E3 Lithium Files Clearwater Project NI 43-101 Technical Report
Via PressReach
Tickers EEMMF TSX-V:ETL
University of Texas Expands Emergency Communications
Via PressReach
Topics Artificial Intelligence
Exposures Artificial Intelligence
Tickers KSCP
< Previous 1 2 3 4 5 6 7 8 9
...
37 38 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.